Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder

NCT00805493 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Stopped Insufficient recruitment of participants

Conditions

Bipolar Disorder
Anxiety Disorders
Bipolar Affective Disorder
Bipolar Depression

Interventions

DRUG: Riluzole

Sponsor

National Institute of Mental Health (NIMH)